1. Anderson I. Alopecia areata: a clinical study. Br Med J. 1950. 2:1250–1252.
Article
2. Maffei C, Fossati A, Rinaldi F, Riva E. Personality disorders and psychopathologic symptoms in patients with androgenetic alopecia. Arch Dermatol. 1994. 130:868–872.
Article
3. Fossati A, Rinaldi F, Maestroni L, Cappio F, Maffei C. Trichologic consultation and personality disorders. G Ital Dermatol Venereol. 1993. 128:101–108.
4. Kantor J, Kessler LJ, Brooks DG, Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol. 2003. 121:985–988.
Article
5. Hadshiew IM, Foitzik K, Arck PC, Paus R. Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. J Invest Dermatol. 2004. 123:455–457.
Article
6. de Koning EB, Passchier J, Dekker FW. Psychological problems with hair loss in general practice and the treatment policies of general practitioners. Psychol Rep. 1990. 67(3 Pt 1):775–778.
Article
7. Kim DH, Kim SN. The effect on hair loss for impression formation and interpersonal anxiety. Korean J Aesthet Cosmet Soc. 2010. 8:1–12.
8. Schlenker BR, Leary MR. Social anxiety and self-presentation: a conceptualization and model. Psychol Bull. 1982. 92:641–669.
9. Leary MR, Kowalsi RM, Campbell CD. Self-presentational concerns and social anxiety: the role of generalized impression expectancies. J Res Pers. 1988. 22:308–321.
Article
10. Kim SJ, Kang SH, Kim WJ, Kim YM. The variation factors of severity: adjusted length of stay in CABG. J Korean Soc Quality Manage. 2011. 39:391–399.
11. Yong WS, Park IS, Kang SH, Kim WJ, Kim KH, Kim KK, Park NY. Development of hypertension predictive model. J Korean Soc Health Educ Promot. 2006. 23:13–28.
12. Park IS, Yong WS, Kim YM, Kang SH, Han JT. A development of a tailored follow up management model using the data mining technique on hypertension. Korean J Appl Stat. 2008. 21:649–657.
Article
13. Luk JM, Lam BY, Lee NP, Ho DW, Sham PC, Chen L, Peng J, Leng X, Day PJ, Fan ST. Artificial neural networks and decision tree model analysis of liver cancer proteomes. Biochem Biophys Res Commun. 2007. 361:68–73.
Article
14. Saritas I, Ozkan IA, Sert IU. Prognosis of prostate cancer by artificial neural networks. Expert Syst Appl. 2010. 37:6646–6650.
Article
15. Sinclair R, Wewerinke M, Jolley D. Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol. 2005. 152:466–473.
Article
16. Severi G, Sinclair R, Hopper JL, English DR, McCredie MR, Boyle P, Giles GG. Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors. Br J Dermatol. 2003. 149:1207–1213.
Article
17. Diaz-Atienza F, Gurpegui M. Environmental stress but not subjective distress in children or adolescents with alopecia areata. J Psychosom Res. 2011. 71:102–107.
Article
18. Kim EK, Jeoung MY. A study on physical symptom of people who has alopecia using CMI method. J Korean Soc Cosmetol. 2009. 15:440–450.
19. Lim HS, Lee CH, Ro BI. A clinical study of androgenetic alopecia (1994). Korean J Investig Dermatol. 1997. 4:27–34.
20. Matzer F, Egger JW, Kopera D. Psychosocial stress and coping in alopecia areata: a questionnaire survey and qualitative study among 45 patients. Acta Derm Venereol. 2011. 91:318–327.
Article
21. Fischer TW, Schmidt S, Strauss B, Elsner P. Hairdex: a tool for evaluation of disease-specific quality of life in patients with hair diseases. Hautarzt. 2001. 52:219–227.